BioHealth News Archive
Omicron subvariants and the changing landscape of COVID-19 | Hub
Omicron is mutating in giant leaps, with scientists racing to keep up. Its diversity is challenging vaccine efficacy and complicating treatment. But this fall,…
Read More
Children’s National Hospital gets federal funding for pandemic preparedness – Washington Business Journal
The grant focuses on a few areas across four years, including addressing health disparities. {iframe}https://www.bizjournals.com/washington/news/2022/07/19/childrens-national-federal-funding-covid-pandemic.html{/iframe}
Read More
Deka Biosciences Breaks Ground on New Facility
GERMANTOWN, Md., July 19, 2022 /PRNewswire/ -- Deka Biosciences announced today that it is breaking ground on a 14,000 square foot office and lab…
Read More
Novavax, advancing COVID-19 shot, recruits AstraZeneca exec as its chief medical officer | Fierce Pharma
On the heels of some big fundraising moves and in the hunt for a COVID-19 vaccine, Novavax is adding some Big Pharma experience to…
Read More
Novavax Announces Expanded Agreement with SK bioscience to Manufacture COVID-19 Vaccine Containing Omicron Variant and Manufacture the Novavax COVID-19 Vaccine in Prefilled Syringes
GAITHERSBURG, Md., July 19, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, has…
Read More
Construction Continues at Progress Labs in Gaithersburg – The MoCo Show
Progress Labs at Progress Way in Gaithersburg, MD is a two-building approximately 495,000 SF development situated on 44 acres with I-270 visibility and access…
Read More
Maryland Inno – Maryland sees an increase in VC dollars in Q2 despite a national decline
Maryland bucked a national trend in venture capital funding in the second quarter of 2022, recording an increase in the number of companies able…
Read MoreMaryland Inno – Baltimore startup Delfi Diagnostics raises $225M with plans to change how lung cancer is diagnosed
Baltimore biotechnology startup Delfi Diagnostics has raised $225 million as it embarks on a 15,000-person trial for its early cancer detection technology. The oversubscribed…
Read More
BioFactura Announces Activation of a $15.9M Contract Option for its Smallpox Biodefense Therapeutic
The contract from BARDA will advance development of an antibody cocktail therapeutic for the treatment of smallpox. FREDERICK, MD. (PRWEB) JULY 15, 2022 BioFactura today…
Read MoreAltus Realty Acquires Pair of Rockville Office Buildings for $26M – Commercial Observer
Altus Realty has acquired Research Square, two office buildings comprising 90,000 square feet in Rockville, Md., for $25.5 million. Westat, an employee-owned research company…
Read More
Materic and LaunchPort Announce Partnership to Drive Advanced Materials Manufacturing for Medical Device Technology – The LaunchPort
July 18, 2022, Baltimore, MD – Materic, a custom manufacturer of advanced materials, and LaunchPort, LLC, a medical device venture center and GMP contract…
Read More
Emergent BioSolutions Announces Appointment of Sujata Dayal to Board of Directors | Emergent BioSolutions Inc.
GAITHERSBURG, Md., July 06, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that the company’s board of directors appointed Sujata Dayal as…
Read More
D.C. region gets boost in CBRE’s new life sciences talent ranking – Washington Business Journal
A new CBRE report ranked the top 25 life sciences research talent clusters for the first quarter. {iframe}https://www.bizjournals.com/washington/news/2022/07/14/dc-area-life-sciences-research-talent-cbre-rank.html{/iframe}
Read More
Canon Medical Systems USA Inc. Announces Expansion of Distributorship with the Acquisition of NXC Imaging – Cardiac Vascular News
Tustin, California, July 11, 2022 (GLOBE NEWSWIRE) — Canon Medical Systems USA Inc., a commercial subsidiary of Canon Medical Systems Corporation and a global…
Read More
NexImmune Announces IND Clearance by the US FDA for NEXI-003 for the Treatment of HPV-Related Cancers
First IND for NexImmune’s AIM nanoparticle platform in solid tumors IND clearance enables commencement of a clinical trial to evaluate NEXI-003, an autologous antigen-specific…
Read More